27 September 2022: Articles
An Unusual Presentation of Neurosarcoidosis
Challenging differential diagnosis, Rare disease
Erdal Sarac A , Sergul A. Erzurum A , Ali Arif C*DOI: 10.12659/AJCR.937125
Am J Case Rep 2022; 23:e937125
Table 2. Table of comparative frequency of clinical neurological manifestations in neurosarcoidosis.
| Neurological features | Frequency | Prognosis* | |
|---|---|---|---|
| Acute | Chornic | ||
| Cranial neuropathy | 50–70% | Good | Good |
| Parenchymal brain lesions | 50% | Fair | Poor |
| Cognitive/behavioral manifestations | 20% | Good | Fair |
| Mentingeal disease | 10–20% | Good | Poor |
| Peripheral neuropathy | 15% | Fair | Fair |
| Seizures | 5–10% | Good | Good |
| Spinal lesions | 5–10% | Good | Fair |
| Myopathy | 1.4–2.3% | Fair | Poor |
| * Acute is defined as 3 months. ** If there is active brain inflammation seizures may be refractory; if the inflammatory process can be controlled seizures usually respond to standard anti-seizure meditory process can be controlled seizures usually respond to standard anti-seizure medications. | |||